3/16
08:43 am
xene
Xenon Pharmaceuticals (XENE) had its price target lowered by Wedbush from $64.00 to $63.00. They now have an "outperform" rating on the stock.
Low
Report
Xenon Pharmaceuticals (XENE) had its price target lowered by Wedbush from $64.00 to $63.00. They now have an "outperform" rating on the stock.
3/15
05:47 am
xene
Xenon Pharmaceuticals (XENE) Climbs 31.7% as Epilepsy Treatment Moves Forward [Yahoo! Finance]
Low
Report
Xenon Pharmaceuticals (XENE) Climbs 31.7% as Epilepsy Treatment Moves Forward [Yahoo! Finance]
3/12
10:04 pm
xene
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares [Yahoo! Finance]
Medium
Report
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares [Yahoo! Finance]
3/12
07:06 pm
xene
Assessing Xenon Pharmaceuticals (XENE) Valuation After A Sharp Recent Share Price Surge [Yahoo! Finance]
Medium
Report
Assessing Xenon Pharmaceuticals (XENE) Valuation After A Sharp Recent Share Price Surge [Yahoo! Finance]
3/12
04:01 pm
xene
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Medium
Report
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
3/11
05:43 pm
xene
Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancements in Psychiatric Therapies | DelveInsight [Yahoo! Finance]
Low
Report
Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancements in Psychiatric Therapies | DelveInsight [Yahoo! Finance]
3/11
02:42 am
xene
Xenon Pharmaceuticals prices upsized $650M public offering at $57/share [Seeking Alpha]
Low
Report
Xenon Pharmaceuticals prices upsized $650M public offering at $57/share [Seeking Alpha]
3/10
10:39 pm
xene
Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
Low
Report
Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
3/10
11:53 am
xene
Xenon hits a ‘home run' in epilepsy; FDA restarts review of Duchenne cell therapy [Yahoo! Finance]
Low
Report
Xenon hits a ‘home run' in epilepsy; FDA restarts review of Duchenne cell therapy [Yahoo! Finance]
3/10
09:47 am
xene
Xenon Pharmaceuticals (XENE) had its price target raised by Wells Fargo & Company from $49.00 to $68.00. They now have an "overweight" rating on the stock.
Low
Report
Xenon Pharmaceuticals (XENE) had its price target raised by Wells Fargo & Company from $49.00 to $68.00. They now have an "overweight" rating on the stock.
3/10
08:35 am
xene
Xenon Pharmaceuticals (XENE) had its price target raised by Wedbush from $47.00 to $64.00. They now have an "outperform" rating on the stock.
Medium
Report
Xenon Pharmaceuticals (XENE) had its price target raised by Wedbush from $47.00 to $64.00. They now have an "outperform" rating on the stock.
3/10
08:03 am
xene
Xenon Pharmaceuticals (XENE) had its price target raised by Deutsche Bank Aktiengesellschaft from $56.00 to $90.00. They now have a "buy" rating on the stock.
Medium
Report
Xenon Pharmaceuticals (XENE) had its price target raised by Deutsche Bank Aktiengesellschaft from $56.00 to $90.00. They now have a "buy" rating on the stock.
3/10
08:03 am
xene
Xenon Pharmaceuticals (XENE) had its price target raised by HC Wainwright from $53.00 to $74.00. They now have a "buy" rating on the stock.
Medium
Report
Xenon Pharmaceuticals (XENE) had its price target raised by HC Wainwright from $53.00 to $74.00. They now have a "buy" rating on the stock.
3/9
06:05 pm
xene
Xenon Pharmaceuticals (XENE) was given a new $100.00 price target by Jefferies Financial Group Inc..
Low
Report
Xenon Pharmaceuticals (XENE) was given a new $100.00 price target by Jefferies Financial Group Inc..
3/9
05:01 pm
xene
Xenon Pharmaceuticals (XENE) was given a new $97.00 price target by Robert W. Baird.
Low
Report
Xenon Pharmaceuticals (XENE) was given a new $97.00 price target by Robert W. Baird.
3/9
05:01 pm
xene
Xenon Pharmaceuticals (XENE) was given a new $97.00 price target by Morgan Stanley.
Low
Report
Xenon Pharmaceuticals (XENE) was given a new $97.00 price target by Morgan Stanley.
3/9
04:05 pm
xene
Xenon Pharmaceuticals (XENE) had its "buy" rating reaffirmed by Guggenheim.
Low
Report
Xenon Pharmaceuticals (XENE) had its "buy" rating reaffirmed by Guggenheim.
3/9
04:01 pm
xene
Xenon Pharmaceuticals Announces Proposed Public Offering
Low
Report
Xenon Pharmaceuticals Announces Proposed Public Offering
3/9
01:52 pm
xene
Analysts tout market potential of Xenon's epilepsy drug on Phase III win [Yahoo! Finance]
Medium
Report
Analysts tout market potential of Xenon's epilepsy drug on Phase III win [Yahoo! Finance]
3/9
01:51 pm
xene
Xenon Pharmaceuticals (XENE) had its price target raised by Needham & Company LLC from $58.00 to $80.00. They now have a "buy" rating on the stock.
Low
Report
Xenon Pharmaceuticals (XENE) had its price target raised by Needham & Company LLC from $58.00 to $80.00. They now have a "buy" rating on the stock.
3/9
01:24 pm
xene
Xenon Pharmaceuticals (XENE) had its price target raised by Robert W. Baird from $63.00 to $97.00. They now have an "outperform" rating on the stock.
Low
Report
Xenon Pharmaceuticals (XENE) had its price target raised by Robert W. Baird from $63.00 to $97.00. They now have an "outperform" rating on the stock.
3/9
12:06 pm
xene
Xenon Pharmaceuticals (XENE) was given a new $89.00 price target by Stifel Nicolaus.
Low
Report
Xenon Pharmaceuticals (XENE) was given a new $89.00 price target by Stifel Nicolaus.
3/9
12:01 pm
xene
Xenon: Shares Soar On Seizure Data, But Valuation May Be Overcooked [Seeking Alpha]
Low
Report
Xenon: Shares Soar On Seizure Data, But Valuation May Be Overcooked [Seeking Alpha]
3/9
11:05 am
xene
Xenon Pharmaceuticals (XENE) had its "buy" rating reaffirmed by Bank of America Corporation.
Low
Report
Xenon Pharmaceuticals (XENE) had its "buy" rating reaffirmed by Bank of America Corporation.
3/9
11:05 am
xene
Xenon Pharmaceuticals (XENE) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Low
Report
Xenon Pharmaceuticals (XENE) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..